DENTSPLY SIRONA Inc. XRAY

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $10.46
Market Cap $2.10B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-3.0% YoY
$3.68B
3-Yr CAGR: -2.1%
Net Income ↑34.3% YoY
-$598.00M
Net Margin: -16.2%
Free Cash Flow ↓-63.0% YoY
$104.00M
FCF Yield: 4.96%
EPS (Diluted) ↑33.0% YoY
$-3.00
Basic: $-3.00
Return on Equity Efficiency
-44.7%
ROA: -11.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (XRAY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $3,745.3M $2,000.9M $429.9M $1.94 $0.31 0.54% $563.4M $438.4M
FY 2017 $3,993.4M +6.6% $2,188.5M $-1,550.0M -460.5% $-6.76 -448.5% $0.35 0.53% $601.9M $457.6M +4.4%
FY 2018 $3,986.3M -0.2% $2,067.8M $-1,011.0M +34.8% $-4.51 +33.3% $0.35 0.94% $499.8M $317.3M -30.7%
FY 2019 $4,029.2M +1.1% $2,165.1M $262.9M +126.0% $1.17 +125.9% $0.38 0.66% $632.8M $509.9M +60.7%
FY 2020 $3,342.0M -17.1% $1,657.0M $-83.0M -131.6% $-0.38 -132.5% $0.40 0.77% $635.0M $548.0M +7.5%
FY 2021 $4,231.0M +26.6% $2,347.0M $411.0M +595.2% $1.87 +592.1% $0.43 0.77% $657.0M $515.0M -6.0%
FY 2022 $3,922.0M -7.3% $2,127.0M $-950.0M -331.1% $-4.41 -335.8% $0.48 1.52% $517.0M $368.0M -28.5%
FY 2023 $3,965.0M +1.1% $2,086.0M $-132.0M +86.1% $-0.62 +85.9% $0.56 1.57% $377.0M $228.0M -38.0%
FY 2024 $3,793.0M -4.3% $1,958.0M $-910.0M -589.4% $-4.48 -622.6% $0.64 3.37% $461.0M $281.0M +23.2%
FY 2025 $3,680.0M -3.0% $1,840.0M $-598.0M +34.3% $-3.00 +33.0% $0.64 5.60% $235.0M $104.0M -63.0%
$

Valuation

Market Price $10.46
Market Cap $2.10B
Enterprise Value $4.01B
P/E Ratio N/A
P/B Ratio 1.56
FCF Yield 4.96%
Dividend Yield 6.12%
Shares Outstanding 200,326,700
%

Profitability & Margins

Gross Margin 50.00%
Operating Margin -11.47%
Net Margin -16.25%
Return on Equity (ROE) -44.66%
Return on Assets (ROA) -11.01%
Asset Turnover 0.68x
Revenue 3-Yr CAGR -2.10%
🛡️

Financial Health & Liquidity

Current Ratio 1.51
Cash Ratio 0.24
Debt / Equity 1.675
Debt / Assets 0.413
Cash & Equivalents $326.00M
Total Debt $2.24B
Book Value / Share $6.68
💧

Cash Flow Efficiency

Operating Cash Flow $235.00M
Capital Expenditures (CapEx) $131.00M
Free Cash Flow $104.00M
OCF / Revenue 6.39%
FCF / Revenue 2.83%
FCF 3-Yr CAGR -34.38%
🏷️

Per Share Metrics

EPS (Diluted) $-3.00
EPS (Basic) $-3.00
Dividends / Share $0.64
Book Value / Share $6.68
EPS YoY Growth 33.04%
🏛️

Balance Sheet (FY 2025)

Total Assets $5.43B
Total Liabilities $4.09B
Stockholders' Equity $1.34B
Current Assets $2.02B
Current Liabilities $1.34B